Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease model: human aging.

M Kuro-o1

  • 1Department of Pathology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9072, USA. kuroo.makoto@pathology.swmed.edu

Trends in Molecular Medicine
|April 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition.

Oncogene·2014
Same author

Adhesion of klotho-deficient eryptotic erythrocytes to endothelial cells.

Acta physiologica (Oxford, England)·2012
Same author

Generalized neuromuscular hypoplasia, reduced smooth muscle myosin and altered gut motility in the klotho model of premature aging.

Neurogastroenterology and motility·2011
Same author

Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.

Oncogene·2009
Same author

Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.

Oncogene·2008
Same author

Molecular cytogenetic characterization and chromosomal distribution of the satellite DNA in the genome of Oxya hyla intricata (Orthoptera: Catantopidae).

Cytogenetic and genome research·2005
Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026
Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
See all related articles

Understanding human aging requires better animal models. Recent advancements include novel mouse models with genetic disruptions, offering new tools for aging research.

Area of Science:

  • Gerontology and Molecular Biology
  • Development of Mammalian Aging Models

Background:

  • Limited understanding of human aging's molecular mechanisms.
  • Paucity of suitable animal models hinders aging research.
  • Senescence-accelerated mouse was historically the sole mammalian aging model.

Purpose of the Study:

  • To highlight recent advancements in mammalian aging models.
  • To introduce novel mouse models for studying aging phenotypes.
  • To emphasize the importance of these models for future aging research.

Main Methods:

  • Review of recent literature on aging models.
  • Focus on genetic disruption strategies in mice.
  • Identification of key genes (klotho, telomerase) and premature aging syndromes.

Related Experiment Videos

Main Results:

  • Development of novel mouse models exhibiting multiple aging phenotypes.
  • These models result from targeted gene disruptions.
  • Existing models like the senescence-accelerated mouse are now complemented.

Conclusions:

  • Novel genetically modified mouse models represent significant progress in aging research.
  • These models provide crucial tools for investigating the molecular mechanisms of aging.
  • Further research utilizing these models is expected to advance the field of gerontology.